TrialSignal
Clinical trial intelligence report
FENUA-METABOGOUT : Genetic Landscape of Gout, Inflammation and Metabolic Diseases in French Polynesia.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT07343336
Status
RECRUITING
Phase
registry-stage
Sponsor
Lille Catholic University
Executive brief
Investment-Ready Snapshot
FENUA-METABOGOUT : Genetic Landscape of Gout, Inflammation and Metabolic Diseases in French Polynesia. is a registry-stage clinical asset sponsored by Lille Catholic University in Gout Disease, Metabolic Diseases, Inflammation. SEO and diligence focus: Epidemiological study, Blood and urine tests, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT07343336
Indication
Gout Disease
Modality
gene therapy
Target
Epidemiological study, Blood and urine tests
Intervention
Epidemiological study, Blood and urine tests
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.